On June 12, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) announcement that AVP-825 has met the primary and secondary endpoints in a phase III study. Shares increased an additional 3.5% in the following trading session. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) net profit margin is -74.00%and weekly performance is 0.55%. On last trading day company shares ended up $5.50. Analysts mean target price for the company is $9.33. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) distance from 50-day simple moving average (SMA50) is 22.52%.
Karyopharm Therapeutics Inc(NASDAQ:KPTI) shares almost doubled (up 93.51%) on encouraging initial data from a phase I study on its oncology candidate, selinexor, for patients suffering from multiple myeloma. The new data was also presented at the European Hematology Association (:EHA). Selinexor is a first-in-class oral selective inhibitor of nuclear export (:SINE) compound. Karyopharm Therapeutics Inc(NASDAQ:KPTI) shares advanced 8.52% in last trading session and ended the day on $44.73. KPTI return on assets is -49.90%. Karyopharm Therapeutics Inc(NASDAQ:KPTI) quarterly performance is 5.97%.
On May 23, Agile Therapeutics Inc (NASDAQ:AGRX) priced 9.17M shares at $6.00. RBC Capital and William Blair acted as joint book running managers for the offering. Agile Therapeutics Inc (NASDAQ:AGRX) shares moved up 9.00% in last trading session and was closed at $7.39, while trading in range of $ 6.90 – $7.84. Agile Therapeutics Inc (NASDAQ:AGRX)year to date (YTD) performance is 33.39%.
Fibrocell Science Inc (NYSEMKT:FCSC), announced that it has entered into an exclusive license agreement with The Regents of the University of California. Under the agreement, Fibrocell acquired the rights to commercially apply patented discoveries and technologies resulting from the ongoing scientific collaboration between the University of California at Los Angeles (UCLA) and Fibrocell Science. Fibrocell Science Inc (NYSEMKT:FCSC) ended the last trading day at $4.29. Company weekly volatility is calculated as 13.19% and price to cash ratio as 3.25. Fibrocell Science Inc (NYSEMKT:FCSC)showed a positive weekly performance of 22.92%.
On June 9, 2014, Versartis Inc (NASDAQ:VSAR) announced it will hold a conference call and webcast on Monday, June 23, 2014 at 5:00 p.m. EDT (4:00 p.m. CDT). Versartis Inc (NASDAQ:VSAR) shares moved down -4.73% in last trading session and was closed at $30.00, while trading in range of $29.75 – $32.34. Versartis Inc (NASDAQ:VSAR)year to date (YTD) performance is -4.37%.